Eltrombopag Olamine

Overview

Eltrombopag Olamine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3989691).

API suppliers (22)

Suppliers of Eltrombopag Olamine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Granules India LimitedIndia1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• TAPI NL BVNetherlands1 active DMF
• CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF
• CHEMWERTH INCFrance1 active DMF
• EXTROVIS AGSwitzerland1 active DMF
• Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
• QUIMICA SINTETICA SASpain1 active DMF
• GUANGDONG RAFFLES PHARMATECH CO LTDChina1 active DMF
• OPTIMUS DRUGS PRIVATE LTDIndia1 active DMF
• SHILPA PHARMA LIFESCIENCES LTDIndia1 active DMF
• CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD1 active DMF
• TOPHARMAN TANCHENG CO LTD1 active DMF
• SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
• Shanghai Desano Pharmaceuticals Co., Ltd.China1 active DMF
• Biocon LimitedIndia1 active DMF
• Deva Holding A.Ş.Turkey1 active DMF
• RAKS PHARMA PVT LTDIndia1 active DMF
• Hetero Drugs LimitedIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (41 approved US products), the latest listed US patent on Eltrombopag Olamine expires 1 Feb 2028. Generic API sourcing typically opens up once these lapse.